NCT05540990

Brief Summary

Cerebral Palsy (CP) is considered a neurological disorder caused by a non-progressive brain injury or malformation that occurs while the child's brain is under development. CP primarily affects body movement and muscle coordination. Robot assisted gait training (RAGT) is considered to be a promising approach for improving gait related gross motor function of children and youth with CP. There is weak and inconsistent evidence regarding the use of RAGT for children with gait disorders. Further research is required with increased numbers and with relevant outcome measures to both confirm the effectiveness and clarify training schedules. The aim of this research project is to investigate the effectiveness of robot assisted gait training on improvements of functional gait parameters in children with cerebral palsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 15, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 15, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2023

Completed
Last Updated

February 8, 2024

Status Verified

February 1, 2024

Enrollment Period

10 months

First QC Date

September 2, 2022

Last Update Submit

February 7, 2024

Conditions

Keywords

Cerebral Palsy, Robot assisted gait training, Gait

Outcome Measures

Primary Outcomes (2)

  • Change in GMFM-88 D Item

    The Gross Motor Function Measure (GMFM) is an assessment tool designed and evaluated to measure changes in gross motor function over time or with intervention in children with cerebral palsy. GMFM-88 is a measure developed to evaluate the gross motor function changes in CP children. It has five components: lying and rolling, sitting, kneeling and crawling, standing, and walking. D dimension is for Standing abilities. The score of each dimension is expressed as a percentage of the maximum score. There is a scoring system with each item scored as 0, 1, 2, 3, or "not tested". A scoring key of 0 - does not initiate, 1 - initiates, 2 - partially completes, and 3 - completed, is used. It takes between 20-25 minutes to be completed.

    baseline, 8 weeks, 14 weeks and 20 weeks

  • Change in GMFM-88 E Item

    The Gross Motor Function Measure (GMFM) is an assessment tool designed and evaluated to measure changes in gross motor function over time or with intervention in children with cerebral palsy. GMFM-88 is a measure developed to evaluate the gross motor function changes in CP children. It has five components: lying and rolling, sitting, kneeling and crawling, standing, and walking. E dimension is for Walking, Running \& Jumping abilities. The score of each dimension is expressed as a percentage of the maximum score. There is a scoring system with each item scored as 0, 1, 2, 3, or "not tested". A scoring key of 0 - does not initiate, 1 - initiates, 2 - partially completes, and 3 - completed, is used. It takes between 20-25 minutes to be completed.

    baseline, 8 weeks, 14 weeks and 20 weeks

Secondary Outcomes (5)

  • Change in 6 Minute Walk Test

    baseline, 8 weeks, 14 weeks and 20 weeks

  • Change in 10 Meter Walk Test

    baseline, 8 weeks, 14 weeks and 20 weeks

  • Change in Modified Ashworth Scale

    baseline, 8 weeks, 14 weeks and 20 weeks

  • Change in Goal Attainment Scale (GAS)

    baseline, 8 weeks, 14 weeks and 20 weeks

  • Change in Pediatric Quality of Life Inventory (PedsQL) 3.0 Cerebral Palsy Module (Parent Form)

    baseline, 8 weeks, 14 weeks and 20 weeks

Study Arms (2)

Robotic assisted gait training (RAGT) + conventional physiotherapy (CPt) group

EXPERIMENTAL

This group will receive 15 sessions of robot-assisted gait training (two or three times per week with a maximum of 45 minutes each) and conventional physiotherapy, which is individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.

Device: Robot assisted gait trainingOther: Conventional physiotherapy

Conventional physiotherapy (CPt) group

ACTIVE COMPARATOR

This group will receive conventional physiotherapy, which is individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.

Other: Conventional physiotherapy

Interventions

15 sessions of robot-assisted gait training (two times per week with a maximum of 45 minute each).

Robotic assisted gait training (RAGT) + conventional physiotherapy (CPt) group

individually customized to the needs of the child and usually consists of 2-3 sessions of physiotherapy per week.

Conventional physiotherapy (CPt) groupRobotic assisted gait training (RAGT) + conventional physiotherapy (CPt) group

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • GMFCS Level 2-4
  • Bilateral or unilateral spastic CP
  • Able to follow instructions and communicate pain or discomfort
  • Have a passive range of motion (ROM) of hips and knees within minimum range requirement for robotic assisted training (hip and knee flexion contracture ≤10°, and knee valgus ≤40°)
  • Not having participated in another robotic assisted training regime within the previous 6 months
  • Able to participate in a minimum of 30 minutes robotic assisted training session
  • Able to commit to attendance of two to three times weekly for 15 sessions (to support the primary efficacy analysis)

You may not qualify if:

  • Botulinum toxin type A injection within 3 months
  • Orthopedic surgery on the lower extremity (muscle surgery within the last 9 months, bone surgery within 12 months)
  • Bone fractures, open skin lesions, or circulatory problems
  • Vision and hearing impairments that affect participation in robotic assisted training
  • Epilepsy resistant to medication
  • Cardiopulmonary instability
  • Use of a baclofen pump

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University

Ankara, 06530, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cerebral PalsyMotor Skills Disorders

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurodevelopmental DisordersMental Disorders

Study Officials

  • Birkan Sonel Tur, Prof

    Ankara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 2, 2022

First Posted

September 15, 2022

Study Start

September 15, 2022

Primary Completion

July 26, 2023

Study Completion

July 26, 2023

Last Updated

February 8, 2024

Record last verified: 2024-02

Locations